Adenosine Deaminase 1 as a Biomarker for Diagnosis and Monitoring of Patients with Acute Lymphoblastic Leukemia

BACKGROUND: Acute lymphoblastic leukemia (ALL) is known as the most prevalent pediatric malignancy all around the world. Identification of specific biomarker is necessary for early diagnosis and effective therapy. It is believed that Adenosine deaminase (ADA) as an enzyme involved in the purine salv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebrahimi-Rad, Mina, Khatami, Shohreh, Ansari, Shahla, Jalylfar, Shohreh, Valadbeigi, Shirin, Saghiri, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294093/
https://www.ncbi.nlm.nih.gov/pubmed/30581348
http://dx.doi.org/10.1515/jomb-2017-0042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294093/
https://www.ncbi.nlm.nih.gov/pubmed/30581348
http://dx.doi.org/10.1515/jomb-2017-0042

Ejemplares similares